Could high ALP indicate liver or bone problems?

Elevated alkaline phosphatase (ALP) levels can signal liver disease, bone disorders, or other conditions. While ALP above 120 U/L warrants investigation, additional tests like GGT help determine whether the elevation stems from liver or bone issues.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What is Alkaline Phosphatase (ALP)?

Alkaline phosphatase (ALP) is an enzyme found throughout your body, with the highest concentrations in your liver, bones, kidneys, and digestive system. This enzyme plays crucial roles in breaking down proteins and helping liver function, bone formation, and nutrient absorption. When cells containing ALP are damaged or undergo rapid growth, they release this enzyme into your bloodstream, causing elevated levels that doctors can detect through routine blood tests.

ALP exists in several forms called isoenzymes, each originating from different tissues. The liver and bone isoenzymes make up about 95% of total ALP in healthy adults. This distribution explains why elevated ALP levels often point to problems in these two organ systems. Understanding your ALP levels through regular testing can provide valuable insights into your liver and bone health.

Normal vs. High ALP Levels

Normal ALP levels vary based on age, sex, and laboratory reference ranges. For adults, typical ranges fall between 44-147 U/L, though some labs use slightly different values. Children and adolescents naturally have higher ALP levels due to active bone growth, with levels sometimes reaching 500 U/L during growth spurts. Pregnant women also experience elevated ALP, particularly in the third trimester, due to placental ALP production.

ALP Level Categories and Clinical Significance

Reference ranges may vary by laboratory. Always interpret results in clinical context.
ALP LevelCategoryCommon CausesRecommended Action
44-147 U/L44-147 U/LNormalNo pathologyRoutine monitoring
148-300 U/L148-300 U/LMild elevationFatty liver, healing fracture, pregnancyRepeat test, check GGT
301-600 U/L301-600 U/LModerate elevationHepatitis, early Paget's, bone metastasesComprehensive workup needed
>600 U/L>600 U/LSevere elevationBile obstruction, advanced Paget's, cancerUrgent evaluation required

Reference ranges may vary by laboratory. Always interpret results in clinical context.

High ALP is generally defined as levels exceeding the upper limit of your laboratory's reference range. Mild elevations (up to 2 times normal) might indicate minor liver stress or early bone changes. Moderate elevations (2-4 times normal) often suggest more significant liver or bone disease. Severe elevations (over 4 times normal) typically indicate serious conditions like bile duct obstruction, Paget's disease, or certain cancers. Understanding these ranges helps contextualize your results.

Liver-Related Causes of High ALP

Cholestatic Liver Diseases

Cholestatic conditions, where bile flow from the liver is reduced or blocked, are the most common liver-related causes of elevated ALP. Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) cause progressive damage to bile ducts, leading to ALP elevations often 4-10 times the normal range. Bile duct obstruction from gallstones or tumors can cause dramatic ALP increases within hours to days.

Hepatocellular Diseases

While hepatocellular diseases like hepatitis and cirrhosis primarily elevate liver enzymes ALT and AST, they can also cause modest ALP increases. Alcoholic liver disease typically shows ALP levels 2-3 times normal, often with a characteristic pattern where AST exceeds ALT. Non-alcoholic fatty liver disease (NAFLD) usually causes mild ALP elevation, though levels can increase significantly if the condition progresses to cirrhosis.

Drug-Induced Liver Injury

Numerous medications can cause elevated ALP through liver toxicity. Common culprits include certain antibiotics (amoxicillin-clavulanate, erythromycin), antiepileptic drugs (phenytoin, carbamazepine), and some cardiovascular medications. Herbal supplements and over-the-counter medications like acetaminophen can also elevate ALP when taken in high doses or by susceptible individuals.

Bone-Related Causes of High ALP

Paget's Disease

Paget's disease of bone causes abnormal bone remodeling, leading to enlarged, weakened bones. This condition can cause extremely high ALP levels, sometimes 10-20 times normal. The disease often affects the pelvis, spine, skull, and long bones. Many patients remain asymptomatic, with elevated ALP being the first clue to diagnosis. Bone pain, deformities, and fractures may develop as the disease progresses.

Bone Metastases and Primary Bone Tumors

Cancer that spreads to bones often causes elevated ALP due to increased bone turnover. Prostate, breast, and lung cancers commonly metastasize to bone, causing ALP elevations proportional to the extent of bone involvement. Primary bone cancers like osteosarcoma also elevate ALP, particularly in young patients. Multiple myeloma, despite being a bone marrow cancer, typically doesn't elevate ALP unless there's extensive bone destruction.

Metabolic Bone Diseases

Osteomalacia (soft bones due to vitamin D deficiency) and rickets (the childhood equivalent) cause moderate ALP elevations. Hyperparathyroidism, where excess parathyroid hormone stimulates bone breakdown, also raises ALP levels. Osteoporosis itself doesn't typically elevate ALP unless there are recent fractures, which trigger increased bone formation during healing.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Other Causes of Elevated ALP

Beyond liver and bone conditions, several other factors can elevate ALP. Pregnancy naturally increases ALP due to placental production, with levels doubling or tripling by the third trimester. Certain cancers, particularly lymphomas and leukemias, can elevate ALP through liver infiltration or bone involvement. Hyperthyroidism increases bone turnover, causing mild ALP elevation. Even seemingly benign conditions like recent fatty meals or blood type B or O can cause transient ALP increases.

Genetic variations also influence ALP levels. Familial benign hyperphosphatasemia causes lifelong ALP elevation without any disease. Some individuals have persistent elevation of intestinal ALP, particularly those with blood types B and O who are secretors. These benign causes highlight the importance of clinical context when interpreting ALP results.

How to Determine if High ALP is from Liver or Bone

Distinguishing between liver and bone sources of elevated ALP requires additional testing. The most useful initial test is gamma-glutamyl transferase (GGT), which elevates with liver disease but remains normal in bone conditions. If GGT is elevated alongside ALP, a liver source is likely. If GGT is normal with high ALP, bone disease becomes more probable. Regular monitoring of these markers can help track your liver and bone health over time.

ALP isoenzyme testing can definitively identify the tissue source by separating different forms of ALP. However, this specialized test isn't always necessary. Other liver tests (ALT, AST, bilirubin) and bone markers (calcium, phosphate, vitamin D) often provide sufficient information. Imaging studies like ultrasound for liver or bone scans may be needed based on clinical suspicion.

When to Seek Medical Attention

Isolated mild ALP elevation without symptoms may only require monitoring, but certain situations demand prompt medical evaluation. Seek immediate attention if you experience severe abdominal pain, jaundice (yellowing of skin or eyes), dark urine, or pale stools, as these suggest bile duct obstruction. Persistent bone pain, especially if worse at night, unexplained fractures, or visible bone deformities also warrant urgent assessment.

Even without symptoms, ALP levels more than twice normal deserve medical evaluation. Your doctor will consider your medical history, medications, and risk factors when determining the urgency and extent of workup needed. Early detection of liver or bone disease often leads to better outcomes, making timely evaluation important.

Treatment Approaches for High ALP

Treatment for elevated ALP depends entirely on the underlying cause. Liver-related elevations may require medications like ursodeoxycholic acid for cholestatic diseases, lifestyle modifications for fatty liver disease, or procedures to relieve bile duct obstructions. Bone-related causes might need bisphosphonates for Paget's disease, vitamin D supplementation for osteomalacia, or cancer treatment for metastases.

Supportive measures apply regardless of cause. Maintaining adequate vitamin D and calcium intake supports both liver and bone health. Regular exercise, particularly weight-bearing activities, benefits bone density and liver metabolism. Avoiding alcohol and hepatotoxic medications protects the liver. Some patients benefit from working with specialists like hepatologists or endocrinologists for optimal management.

Monitoring and Prevention Strategies

Regular monitoring helps track treatment effectiveness and detect complications early. Most patients with elevated ALP need testing every 3-6 months, though frequency varies by condition severity. Monitoring should include not just ALP but also related markers like liver enzymes, bone markers, and imaging when appropriate.

Prevention focuses on maintaining overall liver and bone health. This includes maintaining a healthy weight, limiting alcohol consumption, ensuring adequate nutrition (especially calcium and vitamin D), staying physically active, and avoiding unnecessary medications. Regular health screenings can catch problems early when they're most treatable. Some individuals with risk factors may benefit from more frequent monitoring.

Living with Elevated ALP

Many people live normal lives with mildly elevated ALP, especially when the cause is benign or well-controlled. Understanding your specific situation helps reduce anxiety and guides appropriate lifestyle choices. Keep records of your test results to track trends over time. Communicate openly with your healthcare team about symptoms or concerns.

Support groups exist for many conditions causing elevated ALP, from liver diseases to metabolic bone disorders. These communities provide valuable practical advice and emotional support. Remember that elevated ALP is a laboratory finding, not a disease itself. With proper evaluation and management, most underlying causes can be effectively treated or monitored.

References

  1. Sharma U, Pal D, Prasad R. Alkaline phosphatase: an overview. Indian J Clin Biochem. 2014;29(3):269-278.[Link][PubMed][DOI]
  2. Lowe D, Sanvictores T, Zubair M, et al. Alkaline Phosphatase. StatPearls. 2023.[Link][PubMed]
  3. Siddique A, Kowdley KV. Approach to a patient with elevated serum alkaline phosphatase. Clin Liver Dis. 2012;16(2):199-229.[Link][PubMed][DOI]
  4. Ralston SH, Corral-Gudino L, Cooper C, et al. Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline. J Bone Miner Res. 2019;34(4):579-604.[PubMed][DOI]
  5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237-267.[PubMed][DOI]
  6. Kaplan MM. Alkaline phosphatase. N Engl J Med. 1972;286(4):200-202.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ALP at home?

You can test your ALP at home with SiPhox Health's Heart & Metabolic Program or Ultimate 360 Health Program. Both CLIA-certified programs include ALP testing along with other liver function markers, providing comprehensive insights into your metabolic health from the comfort of your home.

What is considered a dangerously high ALP level?

ALP levels more than 4 times the upper normal limit (typically above 500-600 U/L) are considered significantly elevated and require immediate medical evaluation. Levels 10-20 times normal suggest serious conditions like bile duct obstruction or advanced Paget's disease.

Can high ALP levels return to normal?

Yes, ALP levels often normalize once the underlying cause is treated. Removing bile duct obstructions, treating infections, stopping offending medications, or managing bone diseases can lead to ALP normalization within weeks to months.

What other tests are needed if my ALP is high?

Additional tests typically include GGT to differentiate liver from bone sources, complete liver panel (ALT, AST, bilirubin), calcium, phosphate, vitamin D, and potentially imaging studies. Your doctor may also order ALP isoenzymes if the source remains unclear.

Can diet affect ALP levels?

While diet doesn't directly affect ALP levels significantly, maintaining good nutrition supports liver and bone health. Adequate vitamin D and calcium intake is important for bone health, while avoiding excessive alcohol protects the liver. Fatty meals can cause temporary mild ALP elevations.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details